Podcast
MSL Talk: Tom Caravela, Patrina Pellett
Diversity in Medical Affairs and the Power of Networking
Summary
In this episode, Tom Caravela welcomes guests Rachel Kennedy, Lashondra Taylor, and Nirav Shah to discuss the formation and mission of DEMA. They explore the transformative power of networking, sharing Rachel's inspiration behind DEMA and how to engage with the organization. The conversation includes networking success stories and valuable advice for new MSLs and job seekers. The guests outline DEMA's current initiatives and future plans, highlighting upcoming events. The episode concludes with updates from Tom and expressions of appreciation for the listeners' support.
My guests today are Rachel Kennedy, LaShaundra Taylor, and Nirav Shah from DiMA (Diversity in Medical Affairs) and we discuss the story of DiMA and the power of networking.
In this episode we discuss:
- Intro of Rachel, LaShaundra, and Nirav
- The story of how the DiMA group was formed
- What is the mission and how can people join or get involved?
- Their advice for medical affairs professionals on networking and how it can advance their career
- Examples of how networking has helped them in their careers.
- Other advice to those that are looking to build a career in Medical Affairs
networking in medical affairs, DEMA mission, career advancement tips, medical affairs professionals, diversity in medical affairs
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Patrina Pellett
Podcast
MSL Talk: Tom Caravela, Patrina Pellett
Time Audit: YOUR Strategy for Time Management Success
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois
Sponsorship of oncology clinical trials in the United States according to age of eligibility
Article
Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
Article
Karen Geary